Upstate Active Clinical Trials

Study Title:

A Randomized Phase III Trial of Two Standard Dose Fractionation Regimens for Adjuvant Vaginal Brachytherapy in Early Stage Endometrial Cancer

What is the purpose of the study? (in Layman's terms, please describe the study)

The purpose of this study is to see the effects of two different standard of care radiation treatments for endometrial cancer on sexual dysfunction. This study will compare two standard of care treatments: HDR vaginal brachytherapy 3 treatments at a dose of 7 Gy (Group A) to HDR vaginal brachytherapy 6 treatments at a dose of 4 Gy (Group B) for early stage endometrial cancer.

Upstate Institutional Review Board (IRB) Number:

1656974

Study/Protocol ID:

UVA Brachy

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Brittany A Simone

What is involved if I participate?

• How long is the study?
  2 years.
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  Yes
• What tests and procedures are involved?
  Please contact the CRA for more information.

Where will the study take place?

Upstate Cancer Center

Other Information:

Please contact the CRA for more information.”

ClinicalTrials.Gov ID:

NCT03785288

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Erin Bingham, CCRP
Phone: 315-464-3603
Email: [email protected]

Return to Previous Page || Search Again